{"id":"W4240429779","doi":"10.1200/jco.2012.30.27_suppl.99","title":"Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Everolimus; Anastrozole; Hazard ratio; Aromatase inhibitor; Internal medicine; Letrozole; Breast cancer; Interim analysis; Clinical endpoint; Progression-free survival; Oncology; Population; Cancer; Randomized controlled trial; Tamoxifen; Confidence interval; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00560722,0.0009044653,0.001850636,0.000457115,0.0002446096,0.001258448,0.0007853396,0.001004072,0.003787091],"category_scores_gemma":[0.002988124,0.0004194793,0.001729838,0.0006452405,0.000370828,0.0008594512,0.0004341928,0.001897297,0.0008695306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007973767,"about_ca_system_score_gemma":0.001137068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032111,"about_ca_topic_score_gemma":0.003567911,"domain_scores_codex":[0.9990224,0.000591022,0.0000691439,0.00009041247,0.0001498988,0.0000771028],"domain_scores_gemma":[0.9987318,0.0003269266,0.0005016355,0.0001002409,0.00009764188,0.0002418068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7174091,0.003619523,0.01097105,0.004958651,0.007337914,0.0002404629,0.0001912069,0.002056572,0.009290047,0.0004943579,0.0305982,0.2128328],"study_design_scores_gemma":[0.841011,0.04842973,0.05026985,0.001250558,0.009021413,0.0007084886,0.00007478578,0.001139415,0.001532348,0.0007540793,0.04571861,0.00008981709],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6356822,0.2934746,0.002095917,0.008682191,0.001457969,0.005285245,0.03105218,0.0004377234,0.021832],"genre_scores_gemma":[0.7938449,0.09926188,0.008132083,0.01266393,0.001625988,0.009106399,0.06245376,0.0002277441,0.01268325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00560722,"threshold_uncertainty_score":0.02965415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02947625352962269,"score_gpt":0.4068401066455917,"score_spread":0.377363853115969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}